Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab

Gynecol Oncol Rep. 2021 Jul 22:37:100837. doi: 10.1016/j.gore.2021.100837. eCollection 2021 Aug.

Abstract

•Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown.•Pembrolizumab successfully treated a patient with metastatic SCC.•Patients on pembrolizumab should be monitored for immune-related adverse events.

Keywords: Immune checkpoint inhibitor; Mature cystic teratoma; Ovarian squamous cell carcinoma; Pembrolizumab.

Publication types

  • Case Reports